Paradoxically, CXCL13 has been shown to drive several pro-growth and invasive signaling pathways across multiple tumor types, showing that the CXCL13-B cell axis plays a double role in anti-tumor immunity [63]. This evidence concerns the gene CXCL13 and neoplasm.